Daily News
The Future is Now: Deep learning’s impact on cardiovascular care revealed
This wave stems from a profound grasp of deep learning’s potency in artificial intelligence
Published
3 years agoon

In the ever-evolving landscape of healthcare, a paradigm shift is occurring, propelled by the integration of deep learning (DL), a subset of artificial intelligence (AI). This transformative force, dissected in a recent analysis published in JAMA Cardiology (https://jamanetwork.com/journals/jamacardiology/article-abstract/2809845), is led by Dr Ramsey M Wehbe and a team of experts from the Medical University of South Carolina. Their exploration seeks to demystify the intricate workings of DL and its burgeoning role in reshaping cardiovascular imaging practices.
At the heart of this transformative wave is the nuanced understanding of DL as a cognitive powerhouse within the AI realm. Often interchangeably used with general AI, DL stands out as a specialised form designed to emulate the human nervous system’s learning processes. Dr Wehbe’s team emphasizes the capacity of DL models to not only process data but also make decisions at a pace that surpasses human capabilities. This cognitive emulation enables DL models to “think” akin to humans, a trait particularly advantageous for cardiovascular imaging tasks.
The team underscores the training process, where DL models, when fed a copious amount of raw data related to a specific task, can generate inferences directly from images. For instance, a DL model could measure septal wall thickness on echocardiography based on expert consensus labels, predict the risk of right ventricular failure after left ventricular assist device implantation from echocardiographic clips or forecast ischemia on stress echocardiography using labels derived from invasive coronary angiography.
The Crucial Role of Validation in DL Models

Amidst the excitement surrounding DL’s capabilities, the team is quick to underscore a critical step – validation. DL models must undergo rigorous validation after construction to ensure their efficacy in providing valuable insights to clinicians. The failure to do so could result in what the authors aptly term “falsely optimistic performance estimates.” Proper validation involves testing the model’s performance using images from different hospitals, a step deemed essential to confirm the reliability and generalizability of the DL model.
DL in Action: Transforming Cardiovascular Care
DL is already making significant strides in cardiovascular care, showcasing its versatility in various imaging applications. From image planning on cardiac MR images to guiding inexperienced users through image acquisition, reducing noise on CT images, improving image reconstruction, to predicting adverse events based on single-photon emission CT stress polar perfusion maps – DL is proving its mettle. However, it’s crucial to note that many DL models discussed are still works in progress, subject to the scrutiny of the U.S. Food and Drug Administration (FDA) for clinical deployment.
Navigating Challenges in the DL Landscape
As with any technological revolution, challenges abound in the DL landscape. The team points to the complexity of explaining the decision-making process of DL models, introducing the concept of explainable DL as an avenue of exploration to address this challenge. Additionally, they highlight the imperative of remaining vigilant against potential biases in DL models, emphasizing the need for equitable and unbiased predictions.
The authors delve into the challenges of data set drift, where DL models may perform well initially but degrade over time. They advocate for continual learning or model updates to combat this phenomenon. Furthermore, the authors stress the necessity for repeated validation of algorithms in external, unseen datasets, coupled with continuous auditing of model performance.
In conclusion, the analysis offers a comprehensive glimpse into the transformative potential of DL in cardiovascular imaging. As DL continues to carve its path in healthcare, ongoing research, stringent validation processes, and regulatory scrutiny will be pivotal in realizing the full potential of this revolutionary technology. Dr Wehbe and his team’s work stands as a guiding beacon, unraveling the complexities and possibilities that lie at the intersection of deep learning and cardiovascular care. The journey has just begun, and the promise of a revolutionized healthcare landscape beckons on the horizon.
Related Stories
Shalini is an Executive Editor with Apeejay Newsroom. With a PG Diploma in Business Management and Industrial Administration and an MA in Mass Communication, she was a former Associate Editor with News9live. She has worked on varied topics - from news-based to feature articles.